Skip to main content

Table 3 Combinations of prescribed treatments for men and women who survived more than 30 days (n = 4025).

From: Use of evidence-based pharmacotherapy after myocardial infarction in Estonia

Treatment combinations

Men (%)

Women (%)

BB, No. (%)

176 (7.44)

123 (7.41)

ACE/ARB, No. (%)

170 (7.19)

145 (8.73)

Statins, No. (%)

17 (0.72)

12 (0.72)

BB & ACE/ARB, No. (%)

602 (25.45)

525 (31.63)**

BB & statins, No. (%)

130 (5.50)

49 (2.95)**

ACE/ARB and statins, No. (%)

141 (5.96)

63 (3.80)**

BB & ACE/ARB & statins, No. (%)

999 (42.24)

647 (38.98)

No drugs, No. (%)

130 (5.50)

96 (5.78)

Total, No. (%)

2365 (100.00)

1660 (100.00)

  1. BB, beta-blockers; ACE/ARB, angiotensin converting enzyme inhibitors/angiotensin II receptor blockers.
  2. **P < 0.01 for comparison between men and women with Pearson's χ2 test.